Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This new indication is based on the EMPEROR-Reduced trial, which showed a significant 25 per cent reduction in the combined relative risk versus placebo of...
Cardio-renal-metabolic (CRM) conditions affect more than a billion people worldwide and account for up to 20 million deaths annually making it the leading cause of death globally, according to leading healthcare professionals.
/PRNewswire/ -- Boehringer Ingelheim today announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA)...
/PRNewswire/ -- Boehringer Ingelheim today announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA)...
Boehringer Ingelheim today announced the launch of its University of Medicine Excellence (UME). In an unequivocal demonstration of commitment to people development and investment in a continuous learning culture, the company has officially launched UME and appointed the world-renowned Harvard Medical School (HMS) ...